hers health - Search News

News

Hims & Hers Health Stock Stumbles

Why Hims & Hers Health Stock Just Dropped

Hims & Hers Health stock missed on earnings last night. The company grew sales 73% and profits tripled, but Wall Street wanted more. Hims & Hers also reported negative free cash flow for the first half of the year.

Barron's on MSN · 2d

Hims & Hers Health Stock Stumbles After Earnings. Here’s Why.

Hims & Hers Health, a telehealth platform that sells knock offs of popular weight loss drugs, sank in after-hours trading after missing expectations on quarterly earnings and revenue. The stock was down 12% at $55.68 in after-hours trading Monday. It is up 162% so far this year, according to Dow Jones Market Data.

The Wall Street Journal on MSN · 2d

Hims & Hers Health Reports Higher Profit, Revenue

The telehealth-consultation platform posted an increase in profit and revenue for the second quarter on growth in subscribers using personalized treatment plans.

10h

Hims & Hers: From Telehealth To Wellness Hub, The Bright Future

Technological innovation and personalized care are transforming Hims & Hers into a proactive health platform. Read why I ...

Hims & Hers Health Posts Weak Q2; Heading Into More Near-Term Challenges, Analysts Say

Hims & Hers Health (HIMS) stock falls after reporting lower Q2 revenues. Analysts caution about near-term challenges, ...

Stocks to Watch: Palantir Technologies, Hims & Hers Health, Vertex Pharmaceuticals, Kyndryl

Hims & Hers Health posted higher profit and revenue in the second quarter, and the company backed its full-year outlook. In the current quarter, the telehealth-consultation platform forecast revenue ...

Seeking Alpha29d

Hims & Hers Health: Unlocking A $6 Billion Future

Hims & Hers Health reports 111% Q1 2025 revenue growth to $586M, driven by personalized treatments & strong margins. Read why I rate HIMS stock a Strong Buy.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results